Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 696

Similar articles for PubMed (Select 15207952)

1.

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.

Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE trial group.

Lancet. 2004 Jun 19;363(9426):2022-31.

PMID:
15207952
4.

Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.

Zanchetti A, Julius S, Kjeldsen S, McInnes GT, Hua T, Weber M, Laragh JH, Plat F, Battegay E, Calvo-Vargas C, Cieśliński A, Degaute JP, Holwerda NJ, Kobalava J, Pedersen OL, Rudyatmoko FP, Siamopoulos KC, Störset O.

J Hypertens. 2006 Nov;24(11):2163-8.

PMID:
17053536
5.

The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.

Julius S, Weber MA, Kjeldsen SE, McInnes GT, Zanchetti A, Brunner HR, Laragh J, Schork MA, Hua TA, Amerena J, Balazovjech I, Cassel G, Herczeg B, Koylan N, Magometschnigg D, Majahalme S, Martinez F, Oigman W, Seabra Gomes R, Zhu JR.

Hypertension. 2006 Sep;48(3):385-91. Epub 2006 Jul 24.

6.

A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.

Weir MR, Ferdinand KC, Flack JM, Jamerson KA, Daley W, Zelenkofske S.

Hypertension. 2005 Sep;46(3):508-13. Epub 2005 Aug 22.

7.
10.

Valsartan Amlodipine Randomized Trial (VART): design, methods, and preliminary results.

Nakayama K, Kuwabara Y, Daimon M, Shindo S, Fujita M, Narumi H, Mizuma H, Komuro I.

Hypertens Res. 2008 Jan;31(1):21-8. doi: 10.1291/hypres.31.21.

PMID:
18360014
11.

Randomized, double-blind, crossover comparison of amlodipine and valsartan in african-americans with hypertension using 24-hour ambulatory blood pressure monitoring.

Maciejewski S, Mohiuddin SM, Packard KA, Mooss AN, Reyes AP, Aryana A, Hilleman DE.

Pharmacotherapy. 2006 Jul;26(7):889-95.

PMID:
16803420
12.
13.
14.

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.

Viberti G, Wheeldon NM; MicroAlbuminuria Reduction With VALsartan (MARVAL) Study Investigators.

Circulation. 2002 Aug 6;106(6):672-8.

15.

Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.

Zappe D, Papst CC, Ferber P; PROMPT Investigators.

Vasc Health Risk Manag. 2009;5:883-92. Epub 2009 Nov 2.

16.

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.

Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F.

Clin Pharmacol Ther. 1996 Sep;60(3):341-6.

PMID:
8841157
17.

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.

Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT Investigators.

Lancet. 2005 Sep 10-16;366(9489):895-906.

PMID:
16154016
18.

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.

Weber MA, Julius S, Kjeldsen SE, Brunner HR, Ekman S, Hansson L, Hua T, Laragh JH, McInnes GT, Mitchell L, Plat F, Schork MA, Smith B, Zanchetti A.

Lancet. 2004 Jun 19;363(9426):2049-51.

PMID:
15207957
19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk